APR 15, 2015 9:26 AM PDT

Team Determines Structure of Toxin in Respiratory Infections

WRITTEN BY: Will Hector
Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio revealed the molecular structure of the cytotoxin from Mycoplasma pneumoniae, a widespread, highly contagious bacterium that infects the lungs.
Mycoplasmas are the smallest of all bacteria and have proven very difficult to study.
The determination of the structure of the protein, called Community Acquired Respiratory Distress Syndrome (CARDS) toxin, will facilitate drug and vaccine development in asthma and other airway diseases, two members of the research team said. According to the U.S. Centers for Disease Control and Prevention (CDC), 2 million new cases of Mycoplasma pneumoniae infections occur each year in the U.S., but the true extent of the health problem is not known and is probably underestimated.

The finding is in last week's Proceedings of the National Academy of Sciences (PNAS). "We know a lot about how the toxin works, but we did not have its 3-D structure," said corresponding author Joel B. Baseman, Ph.D., professor of microbiology and immunology and director of the Center for Airway Inflammation Research at the UT Health Science Center San Antonio. "The structure shows us the molecular architecture of the protein, which permits the rational design of effective drugs and vaccines to neutralize the injurious effects of CARDS toxin."

"The importance of the structure is that it gives us a detailed picture of the protein machine that causes the damage in the lungs linked to asthma and adult respiratory distress syndrome (ARDS)," said lead author P. John Hart, Ph.D. professor of biochemistry and director of the X-ray Crystallography Core Laboratory at the UT Health Science Center.

Mycoplasmas are the smallest of all bacteria and have proven very difficult to study. Dr. Baseman's laboratory discovered the CARDS Toxin in 2006, a finding that was called, at the time, one of the most important in the field since the discovery of the classical toxins of cholera, diphtheria and pertussis. The latter, pertussis toxin, is the agent that causes whooping cough.

The CARDS toxin structure is unique, said Dr. Hart, who occupies the Ewing Halsell-President's Council Distinguished Chair in Biochemistry at the Health Science Center. "In comparison to cholera and pertussis toxins, which have similar action and molecular architectures, the overall organization of CARDS toxin is completely different," Dr. Hart said.

Mycoplasma pneumoniae is spread by sneezing, coughing, talking and touching hands to the nose. It is thought to be responsible for millions of cases of child and adult asthma. This bacterium infects and colonizes the lungs and secretes the CARDS toxin, resulting in extensive airway injury accompanied by fever, excessive mucus secretion, wheezing and hyper-inflammation. Blocking the toxin could prove to be a major advance in the prevention and care of a wide range of acute and chronic airway diseases, Dr. Baseman said.

(Sources: The Pulmonary Paper; Medical News Today)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
AUG 19, 2020
Immunology
Cancer Mutation Improves Chemo Drug Performance
AUG 19, 2020
Cancer Mutation Improves Chemo Drug Performance
When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcom ...
AUG 25, 2020
Immunology
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
AUG 25, 2020
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
NOV 01, 2020
Cell & Molecular Biology
There's More to Neutrophil Function Than We Knew
NOV 01, 2020
There's More to Neutrophil Function Than We Knew
Neutrophils are an abundant type of white blood cell that circulate in the blood that can provide a general defense aga ...
Loading Comments...